{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:39:18Z","timestamp":1780436358407,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ygyno.2020.03.025","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:27:29Z","timestamp":1585700849000},"page":"619-623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous endometrial carcinoma"],"prefix":"10.1016","volume":"157","author":[{"given":"Jennifer J.","family":"Mueller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Pedra Nobre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenya","family":"Braxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaled M.","family":"Alektiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Mario M.","family":"Leitao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Aghajanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lora H.","family":"Ellenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem R.","family":"Abu-Rustum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2020.03.025_bb0005","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2020.03.025_bb0010","unstructured":"Surveillance, Epidemiology, and End Results Program (SEER). Cancer Stat Facts: Uterine Cancer. https:\/\/seer.cancer.gov\/statfacts\/html\/corp.html. Accessed 2\/10\/20."},{"issue":"2","key":"10.1016\/j.ygyno.2020.03.025_bb0015","doi-asserted-by":"crossref","first-page":"170","DOI":"10.6004\/jnccn.2018.0006","article-title":"Uterine neoplasms, version 1.2018, NCCN Clinical Practice guidelines in oncology","volume":"16","author":"Koh","year":"2018","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"1","key":"10.1016\/j.ygyno.2020.03.025_bb0020","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ygyno.2019.10.028","article-title":"Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer","volume":"156","author":"Staskenko","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2020.03.025_bb0025","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/modpathol.2017.15","article-title":"CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence","volume":"30","author":"Kurnit","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2020.03.025_bb0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Levine","year":"2013","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ygyno.2020.03.025_bb0035","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/annonc\/mdy058","article-title":"Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series","volume":"29","author":"Kommoss","year":"2018","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.03.025_bb0040","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ygyno.2017.09.030","article-title":"Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease","volume":"147","author":"Ducie","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.03.025_bb0045","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ygyno.2015.12.028","article-title":"Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion","volume":"140","author":"Zahl Eriksson","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2020.03.025_bb0050","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ygyno.2018.08.022","article-title":"Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: a sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy","volume":"151","author":"Schlappe","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2020.03.025_bb0055","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ygyno.2017.05.027","article-title":"Sentinel lymph node mapping and staging in endometrial cancer: a Society of Gynecologic Oncology literature review with consensus recommendations","volume":"146","author":"Holloway","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.03.025_bb0060","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/ijgc-2018-000075","article-title":"Current state of sentinel lymph nodes for women with endometrial cancer","volume":"29","author":"Rossie","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2020.03.025_bb0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ygyno.2019.10.005","article-title":"Sentinel lymph node mapping alone compared to more extensive lymphadenectomy in patients with uterine serous carcinoma","volume":"156","author":"Basaran","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.03.025_bb0070","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1470-2045(17)30068-2","article-title":"A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study","volume":"18","author":"Rossi","year":"2017","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.03.025_bb0075","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2019.30.e35","article-title":"Sentinel lymph node mapping in endometrial and cervical cancer: a survey of practices and attitudes in gynecologic oncologists","volume":"30","author":"Chambers","year":"2019","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.03.025_bb0080","unstructured":"SGO Clinical Practice Statement: The Role of Sentinel Lymph Node Mapping in Endometrial Cancer. https:\/\/www.sgo.org\/clinical-practice\/guidelines\/the-role-of-sentinel-lymph-node-mapping-in-endometrial-cancer\/. Accessed 2\/10\/20."},{"issue":"2","key":"10.1016\/j.ygyno.2020.03.025_bb0085","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ygyno.2011.04.030","article-title":"Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes","volume":"122","author":"Khoury-Collado","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.03.025_bb0090","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ygyno.2013.09.027","article-title":"Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion","volume":"131","author":"Kim","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2020.03.025_bb0095","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/IGC.0b013e3182954da8","article-title":"Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging","volume":"23","author":"Kim","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"8 Suppl","key":"10.1016\/j.ygyno.2020.03.025_bb0100","first-page":"2035","article-title":"Surgical pathologic spread patterns of endometrial cancer","volume":"60","author":"Creasman","year":"1987","journal-title":"A Gynecologic Oncology Group Study. Cancer."},{"issue":"2","key":"10.1016\/j.ygyno.2020.03.025_bb0105","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1525-1438.2007.00996.x","article-title":"The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology","volume":"18","author":"Chi","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2020.03.025_bb0110","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ygyno.2017.03.017","article-title":"Surgical-pathological findings in type 1 and 2 endometrial cancer: an NRG oncology\/gynecologic oncology group study on GOG-210 protocol","volume":"145","author":"Creasman","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.03.025_bb0115","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ygyno.2012.02.021","article-title":"The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes","volume":"125","author":"Barlin","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2020.03.025_bb0120","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1245\/s10434-015-5040-z","article-title":"Low-volume lymph node metastasis discovered during sentinel lymph node mapping for endometrial carcinoma","volume":"23","author":"St. Clair","year":"2016","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2020.03.025_bb0125","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ygyno.2017.05.024","article-title":"Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: does adjuvant treatment matter?","volume":"146","author":"Plante","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.03.025_bb0130","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ygyno.2018.09.021","article-title":"Patterns of FIRST recurrence of stage IIIC1 endometrial cancer with no PARAAORTIC nodal assessment","volume":"151","author":"Aloisi","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.03.025_bb0135","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ygyno.2018.07.020","article-title":"Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: evaluation of the pilot phase of the PORTEC-4a trial","volume":"151","author":"Wortman","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.03.025_bb0140","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/AOG.0000000000001181","article-title":"Utilization and outcomes of ovarian conservation in premenopausal women with endometrial Cancer","volume":"127","author":"Wright","year":"2016","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.ygyno.2020.03.025_bb0145","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/AOG.0000000000001647","article-title":"Ovarian conservation and overall survival in young women with early-stage low-grade endometrial cancer","volume":"128","author":"Matsuo","year":"2016","journal-title":"Obstet. Gynecol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582030250X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582030250X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:50:24Z","timestamp":1758772224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082582030250X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S009082582030250X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.03.025","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous endometrial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}